Skip to main content

  • Sustained Safety and Efficacy of Magnesium Reabsorbable Scaffold: 2-Year Follow-Up Analysis From First Magmaris Multicenter Italian Registry

    • Posted: 07/14/2022
    • Author:

      Stefano Galli, Sarah Troiano, Altin Palloshi, Claudio Rapetto, Francesco Pisano, Gianfranco Aprigliano, Massimo Leoncini, Paolo Ravagnani, Martina Del Maestro and Piero Montorsi

    • 2022CRM

    Abstract

    Background

    Magnesium Reabsorbable Scaffold (MRS), is the newest reabsorbable technology with low thrombogenicity, short scaffolding time and almost complete resorption at 12-months (95%). Preliminary 12-months data in selected patients has shown that safety and efficacy are comparable with second generation Drug Eluting Stent (DES). Magmaris Multicenter registry showed 1-and 2-years clinical outcome on the first patients suitable for MRS enrolled in 4 Italian centers.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details